FREDERICK, Md., Jan. 27, 2009 (GLOBE NEWSWIRE) -- BioElectronics Corp. (Pink Sheets:BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced revolutionary relief for menstrual discomfort. The new product named "Allay" is available immediately and will soon be available in retail outlets in Europe, Asia, Canada and Latin America.
The Allay product, which is based on proven and effective ActiPatch(tm) technology, uses electromagnetic pulse therapy to reduce many of the symptoms and discomfort associated with a woman's menstrual cycle. Approximately 50% of women experience such symptoms, with approximately 30% of women having to curtail normal activities due to the pain and discomfort. While millions of women suffer, very few solutions exist. The Allay product is specifically designed to fill this need.
"The Allay device is a natural extension of the use of ActiPatch technology. Knowing the positive benefits of low frequency pulse electromagnetic fields after invasive surgery, applying it to the problem of menstrual discomfort is a logical and no risk extension of those potential benefits. The product is easy to wear, well accepted by the patient, and has no downside," commented Dr. Barry Eppley of Indianapolis, Indiana. "The product is a non-drug, anti-inflammatory therapy that is immediately reversible and affordable. While it will not eliminate all menstrual pain in every patient, it will clearly be of benefit for many women."
CEO of BioElectronics Andrew Whelan added, "We are very excited about the introduction of this new product. Thus far, reaction has been very positive, with many of our retail oriented distributors expressing significant interest and already placing orders. We expect this to be our biggest product to date and we are very positive about the revenue generation possibilities."
About BioElectronics Corporation
BioElectronics Corporation is the maker of the ActiPatch(tm), RecoveryRx(tm), HealFast and Allay family of inexpensive, disposable drug-free anti-inflammatory devices. These devices utilize embedded battery operated microchips that deliver weeks of home therapy for $39.95. The unique delivery system, using patented technology, provides a cost-effective patient friendly method to reduce soft tissue pain and swelling. For more information please see www.bioelectronics.com
Safe Harbor Statement
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the company has no control.